PeripheralA Randomized Trial of the Optimum Duration of Acoustic Pulse Thrombolysis Procedure in Acute Intermediate-Risk Pulmonary Embolism: The OPTALYSE PE Trial
Graphical abstract
Key Words
Abbreviations and Acronyms
Cited by (0)
This research study was funded by Ekos/BTG. Dr. Tapson served as the principal investigator for the trial; has received research support from BiO2 Medical, Bayer, Ekos/BTG, Daiichi-Sankyo, Inari, Janssen, and Portola; has received consulting fees from Bayer and Janssen; and serves as president of the U.S. Pulmonary Response Team Consortium. Dr. Sterling has received research funding from Ekos/BTG, Penumbra, and Angiodynamics; and consulting fees from Ekos/BTG and Boston Scientific. Dr. Jones has received consulting fees from Medtronic, Edwards Lifesciences, St. Jude Medical, Cordis, Ekos/BTG, and Abbott; and speaking honoraria from Ekos/BTG and Abbott. Dr. Elder has received consulting fees and speaking honoraria from Ekos/BTG. Dr. Brower has received consulting fees from Sirtex, Merit Medical, and Ekos/BTG. Dr. Maholic has received consulting fees from Ekos/BTG; speaking honoraria from Abbott Vascular; and serves on the Pulmonary Embolism Response Team Consortium Board of Directors. Dr. Ross has received consulting fees from Zimmer Biomet. Dr. Natarajan has received research support from Cook Medical; and consulting fees from BTG, CSI, Abbott, Gore, and Cook Medical. Dr. Tamaddon has received consulting fees and speaking honoraria from Cook Medical. Dr. Piracha has received speaking honoraria from Novartis, Janssen, and AstraZeneca. Dr. Englehart has received speaking honoraria from Ekos/BTG, Gore, and Janssen. Dr. Marques has received consulting fees from Medtronic. Dr. Sharp has received research support, consulting fees, and speaking honoraria from Ekos/BTG. Dr. Piazza has received research support from Ekos/BTG, Bristol-Myers Squibb, Daiichi-Sankyo, and Janssen; and serves on the scientific advisory panel for Portola. Dr. Goldhaber has received research support from BiO2 Medical, Bayer, Ekos/BTG, Daiichi-Sankyo, Inari, Janssen, and Portola; and consulting fees from Bayer and Janssen. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.